The Patent Finder

Peptide Constructs and Assay Systems

Prognosys Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 13/442,637, filed Apr 9, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,340,232Peptide Constructs and Assay Systems
In force
 · High confidence
UsedRemaining
Prognosys Biosciences, Inc.In forceHigh confidence
US 9,958,454Peptide Constructs and Assay Systems
In force
 · High confidence
Prognosys Biosciences, Inc.In forceHigh confidence
Application 13/442,637Peptide Constructs and Assay Systems
Abandoned
Abandoned May 26, 2016
Prognosys Biosciences, Inc.AbandonedAbandoned May 26, 2016
Application 17/727,618Peptide Constructs and Assay Systems
Pending
Not granted
Prognosys Biosciences, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Prognosys Biosciences, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited